04.02.2005 19:38:00

Robert P. Collins Named Chairman of Atlanta Chapter, Society for Human

Robert P. Collins Named Chairman of Atlanta Chapter, Society for Human Resource Management


    Business Editors

    ATLANTA--(BUSINESS WIRE)--Feb. 4, 2005--Serologicals Corporation (NASDAQ: SERO) today announced that Robert P. Collins, Vice President, Human Resources, has been named Chairman of the Board for the Atlanta Chapter of the Society for Human Resource Management. Collins has served as a member of the board since 2004.
    "I am honored to serve the membership of SHRM - Atlanta by being elected Chairman of the Board of this key organization. SHRM - Atlanta is dedicated to serving the area's HR professionals while advancing our profession through many initiatives that are underway at the local, state and national level," said Collins. "I am looking forward to working with Gary Wheeler, President of the Chapter and his Leadership Team to accomplish our goals."
    SHRM - Atlanta, founded in 1965, is Metro Atlanta's most active resource for advancing Human Resources professionals. The Chapter serves the needs of HR professionals by providing the most essential and comprehensive resources available. As an influential voice, SHRM also advances the human resource profession by ensuring that HR is recognized as an essential partner in developing and executing organizational strategy. The Atlanta Chapter in one of the largest SHRM chapters in the US with over 2,000 members representing more than 1,000 corporations and organizations within the Metro Atlanta area.

    Serologicals Corporation (NASDAQ: SERO), headquartered in Atlanta, GA., is a global leader in developing and commercializing consumable biological products, enabling technologies and services in support of biological research, drug discovery, and the bioprocessing of life-enhancing products. Our customers include researchers at major life science companies and leading research institutions involved in key disciplines, such as neurology, oncology, hematology, immunology, cardiology, proteomics, infectious diseases, cell signaling and stem cell research. In addition, Serologicals is the world's leading provider of monoclonal antibodies for the blood typing industry
    Serologicals employs a total of more than 1,000 people worldwide in three Serologicals' companies: Chemicon International, headquartered in Temecula, CA, Upstate Group, LLC, headquartered in Charlottesville, VA. and Celliance Corporation, headquartered in Atlanta, GA.
    Serologicals is a registered trademark of Serologicals Royalty Company.
    For more information, please visit our website: www.serologicals.com.

--30--AN/at*

CONTACT: Serologicals Corporation, Atlanta Bill Davis, 678-728-2018

KEYWORD: GEORGIA INDUSTRY KEYWORD: HUMAN RESOURCES BIOTECHNOLOGY MANAGEMENT CHANGES SOURCE: Serologicals Corporation

Copyright Business Wire 2005

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Serologicals Corp.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Serologicals Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 218,17 0,83%